Adial Pharmaceuticals Inc (ADIL)

Adial Pharmaceuticals Inc (ADIL) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $12.2M; returns 1 day -7.1%, 1 week +12.3%, 1 year -56.3%.

Adial Pharmaceuticals Inc. (ADIL) is a clinical-stage biopharmaceutical company primarily focused on developing treatments for addiction and related disorders. The company currently generates negligible revenue from product sales, with its financial inflows driven by capital raises through equity and debt financing, as well as non-recurring milestone payments from non-core asset monetization.

Groups ADIL belongs to

• Recent Reverse Splits
• Clinical Stage Biopharma
• Biotechnology
• Biopharmaceutical
• Precision Medicine
• Healthcare
• Life Sciences
• Clinical Stage
• Health Diagnostics and Imaging

ADIL financial model: income statement, cash flow and balance sheet